AKT1 and colorectal carcinoma: In the present study, we demonstrated that VJ, a natural small molecule, can overcome the aberrant activation of the AKT and Notch1 signaling pathways, resulting in significant inhibition of proliferation and EMT in both in vitro and in vivo CRC models without inducing noticeable toxicity.